Risk Factors for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and Presence of Anti-SARS-CoV-2 Antibodies Among University Student Dormitory Residents, September-November 2020.

COVID-19 SARS-CoV-2 risk factor serology university

Journal

Open forum infectious diseases
ISSN: 2328-8957
Titre abrégé: Open Forum Infect Dis
Pays: United States
ID NLM: 101637045

Informations de publication

Date de publication:
Sep 2021
Historique:
received: 05 04 2021
accepted: 29 07 2021
entrez: 23 9 2021
pubmed: 24 9 2021
medline: 24 9 2021
Statut: epublish

Résumé

Multiple severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreaks occurred at universities during Fall 2020, but little is known about risk factors for campus-associated infections or immunity provided by anti-SARS-CoV-2 antibodies in young adults. We conducted surveys and serology tests among students living in dormitories in September and November to examine infection risk factors and antibody presence. Using campus weekly reverse-transcription polymerase chain reaction (RT-PCR) test results, the relationship between survey responses, SARS-CoV-2 antibodies, and infections was assessed. Of 6136 students, 1197 completed the survey and 572 also completed serologic testing in September compared with 517 and 414 in November, respectively. Participation in fraternity or sorority events (adjusted risk ratio [aRR], 1.9 [95% confidence interval {CI}, 1.4-2.5]) and frequent alcohol consumption (aRR, 1.6 [95% CI, 1.2-2.2]) were associated with SARS-CoV-2 infection. Mask wearing during social events (aRR, 0.6 [95% CI, .6-1.0]) was associated with decreased risk. None of the 20 students with antibodies in September tested positive for SARS-CoV-2 during the semester, while 27.8% of students who tested RT-PCR positive tested negative for antibodies in November. Frequent drinking and attending social events were associated with SARS-CoV-2 infection. Antibody presence in September appeared to be protective from reinfection, but this finding was not statistically significant.

Sections du résumé

BACKGROUND BACKGROUND
Multiple severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreaks occurred at universities during Fall 2020, but little is known about risk factors for campus-associated infections or immunity provided by anti-SARS-CoV-2 antibodies in young adults.
METHODS METHODS
We conducted surveys and serology tests among students living in dormitories in September and November to examine infection risk factors and antibody presence. Using campus weekly reverse-transcription polymerase chain reaction (RT-PCR) test results, the relationship between survey responses, SARS-CoV-2 antibodies, and infections was assessed.
RESULTS RESULTS
Of 6136 students, 1197 completed the survey and 572 also completed serologic testing in September compared with 517 and 414 in November, respectively. Participation in fraternity or sorority events (adjusted risk ratio [aRR], 1.9 [95% confidence interval {CI}, 1.4-2.5]) and frequent alcohol consumption (aRR, 1.6 [95% CI, 1.2-2.2]) were associated with SARS-CoV-2 infection. Mask wearing during social events (aRR, 0.6 [95% CI, .6-1.0]) was associated with decreased risk. None of the 20 students with antibodies in September tested positive for SARS-CoV-2 during the semester, while 27.8% of students who tested RT-PCR positive tested negative for antibodies in November.
CONCLUSIONS CONCLUSIONS
Frequent drinking and attending social events were associated with SARS-CoV-2 infection. Antibody presence in September appeared to be protective from reinfection, but this finding was not statistically significant.

Identifiants

pubmed: 34552995
doi: 10.1093/ofid/ofab405
pii: ofab405
pmc: PMC8436379
doi:

Types de publication

Journal Article

Langues

eng

Pagination

ofab405

Informations de copyright

Published by Oxford University Press on behalf of Infectious Diseases Society of America 2021.

Références

MMWR Morb Mortal Wkly Rep. 2020 Oct 02;69(39):1416-1418
pubmed: 33001871
Cell. 2020 Oct 1;183(1):158-168.e14
pubmed: 32979941
Nat Commun. 2020 Oct 9;11(1):5097
pubmed: 33037218
MMWR Morb Mortal Wkly Rep. 2020 Nov 27;69(47):1762-1766
pubmed: 33237893
Nat Microbiol. 2020 Dec;5(12):1598-1607
pubmed: 33106674
N Engl J Med. 2021 Feb 11;384(6):533-540
pubmed: 33369366
Nat Med. 2020 May;26(5):676-680
pubmed: 32371934
JAMA. 2020 Nov 3;324(17):1727-1728
pubmed: 32991681
JAMA Netw Open. 2020 Sep 1;3(9):e2021892
pubmed: 32975575
MMWR Morb Mortal Wkly Rep. 2021 Jan 29;70(4):114-117
pubmed: 33507887
Sci Immunol. 2020 Oct 8;5(52):
pubmed: 33033172
MMWR Morb Mortal Wkly Rep. 2020 Jul 03;69(26):830-835
pubmed: 32614814
MMWR Morb Mortal Wkly Rep. 2021 Jan 08;70(1):14-19
pubmed: 33411699
Clin Infect Dis. 2020 Nov 04;:
pubmed: 33147319
mSphere. 2020 Oct 21;5(5):
pubmed: 33087517
PLoS One. 2020 Nov 2;15(11):e0241327
pubmed: 33137155
MMWR Morb Mortal Wkly Rep. 2021 Jan 08;70(1):20-23
pubmed: 33411698
JAMA Netw Open. 2020 Jul 1;3(7):e2016818
pubmed: 32735339
J Infect. 2021 Apr;82(4):e29-e30
pubmed: 33373652
Drug Alcohol Depend. 2010 Jan 1;106(1):16-20
pubmed: 19758771
Sci Immunol. 2020 Oct 8;5(52):
pubmed: 33033173

Auteurs

Hannah E Segaloff (HE)

COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta Georgia, USA.
Wisconsin Department of Health Services, Madison, Wisconsin, USA.

Devlin Cole (D)

Wisconsin Department of Health Services, Madison, Wisconsin, USA.
School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin, USA.

Hannah G Rosenblum (HG)

COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta Georgia, USA.

Christine C Lee (CC)

COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Laboratory Leadership Service, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Clint N Morgan (CN)

COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Patrick Remington (P)

School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin, USA.

Collin Pitts (C)

School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin, USA.
University Health Services, University of Wisconsin-Madison, Madison, Wisconsin, USA.

Patrick Kelly (P)

School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin, USA.
University Health Services, University of Wisconsin-Madison, Madison, Wisconsin, USA.

Jake Baggott (J)

University Health Services, University of Wisconsin-Madison, Madison, Wisconsin, USA.

Allen Bateman (A)

Wisconsin State Laboratory of Hygiene, Madison, Wisconsin, USA.

Tarah Somers (T)

COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Jeanne Ruff (J)

COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta Georgia, USA.

David Payne (D)

COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Laboratory Leadership Service, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Rodel Desamu-Thorpe (R)

COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Monique A Foster (MA)

COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Dustin W Currie (DW)

COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta Georgia, USA.

Glen R Abedi (GR)

COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Ryan Westergaard (R)

Wisconsin Department of Health Services, Madison, Wisconsin, USA.
School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin, USA.

Christopher H Hsu (CH)

COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Jaqueline E Tate (JE)

COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Hannah L Kirking (HL)

COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Classifications MeSH